Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction (Q37444118)
Jump to navigation
Jump to search
scientific article published on 23 July 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction |
scientific article published on 23 July 2009 |
Statements
1 reference
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction (English)
1 reference
Stephen G Ellis
1 reference
Jay H Traverse
1 reference
Timothy D Henry
1 reference
Douglas E Vaughan
1 reference
Carl J Pepine
1 reference
James T Willerson
1 reference
David X M Zhao
1 reference
Linda B Piller
1 reference
Marc S Penn
1 reference
Barry J Byrne
1 reference
Emerson C Perin
1 reference
Adrian P Gee
1 reference
Antonis K Hatzopoulos
1 reference
David H McKenna
1 reference
John R Forder
1 reference
Doris A Taylor
1 reference
Christopher R Cogle
1 reference
Rachel E Olson
1 reference
Beth C Jorgenson
1 reference
Shelly L Sayre
1 reference
Rachel W Vojvodic
1 reference
David J Gordon
1 reference
Sonia I Skarlatos
1 reference
Lemuel A Moye'
1 reference
Robert D Simari
1 reference
Cardiovascular Cell Therapy Research Network (CCTRN)
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference